Вы искали: alendroonhape (Эстонский - Английский)

alendroonhape
alendronic acid

alendroonhape/kolekaltsiferool
alendronic acid / colecalciferol

adrovance alendroonhape ja kolekaltsiferool
adrovance alendronic acid / colecalciferol

adrovance 70 mg/2800 rÜ tabletid alendroonhape/kolekaltsiferool
adrovance 70 mg/2,800 iu tablets alendronic acid /colecalciferol

toimeained on alendroonhape ja kolekaltsiferool (d3-vitamiin).
the active substances are alendronic acid and colecalciferol (vitamin d3).

fosavance 70 mg/ 2800 rÜtabletid alendroonhape alendronaatnaatriumtrihüdraadina/ kolekaltsiferool
fosavance 70 mg/ 2800 iu tablets alendronic acid as alendronate sodium trihydrate/ colecalciferol

adrovance 70 mg / 5600 rÜ tabletid alendroonhape alendronaatnaatriumtrihüdraadina/ kolekaltsiferool
adrovance 70 mg/ 5600 iu tablets alendronic acid as alendronate sodium trihydrate/ colecalciferol

alendroonhape on bifosfonaat, mida on kasutatud osteoporoosi raviks alates 1990. aastate keskpaigast.
alendronic acid is a bisphosphonate that has been used in osteoporosis since the mid-1990s.

adrovance 70 mg/2800 rÜ tabletid adrovance 70 mg/5600 rÜ tabletid alendroonhape/kolekaltsiferool
adrovance 70 mg/2,800 iu tablets adrovance 70 mg/5,600 iu tablets alendronic acid /colecalciferol

alendronate hexal 10 mg tablettide toimeaine alendroonhape alendronaatnaatriumtrihüdraadina on bifosfonaat, mis pärsib osteoklastset luu resorptsiooni, mõjutamata otseselt luude moodustumist.
the active substance in alendronate hexal 10 mg tablets, alendronic acid as sodium alendronate trihydrate, is a bisphosphonate that inhibits osteoclastic bone resorption without any direct effect on bone formation.

et alendroonhape ja d3-vitamiin on kumbki kasutusel ravimites, millel juba on euroopa liidus müügiluba, esitas ettevõte varasematest uuringutest saadud ja kirjanduses avaldatud andmed menopausijärgses eas naiste kohta, kes on kasutanud alendroonhapet ja d3-vitamiini eraldi ravimitena.
because alendronic acid and vitamin d3 are already used separately in authorised medicines in the eu, the company presented data obtained in earlier studies and from the published literature from women who had been through the menopause and who were taking alendronic acid and vitamin d as separate tablets.